Theravance Biopharma TBPH Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's other accrued liabilities?
- Theravance Biopharma (TBPH) reported other accrued liabilities of $988K in Q1 2026.
- How has Theravance Biopharma's other accrued liabilities changed year-over-year?
- Theravance Biopharma's other accrued liabilities decreased by 52.3% year-over-year, from $2.07M to $988K.
- What is the long-term trend for Theravance Biopharma's other accrued liabilities?
- Over 5 years (2020 to 2025), Theravance Biopharma's other accrued liabilities has grown at a -5.9% compound annual growth rate (CAGR), from $2.01M to $1.49M.